BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 18942763)

  • 21. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
    Lutgens MW; van Oijen MG; van der Heijden GJ; Vleggaar FP; Siersema PD; Oldenburg B
    Inflamm Bowel Dis; 2013; 19(4):789-99. PubMed ID: 23448792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
    Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to manage the risk of colorectal cancer in ulcerative colitis.
    Ali RA; Egan LJ
    Curr Drug Targets; 2011 Sep; 12(10):1424-32. PubMed ID: 21466491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation.
    Yamamoto-Furusho JK; Bosques-Padilla F; de-Paula J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Rocha JL; Steinwurz F; Veitia G; Zaltman C
    Rev Gastroenterol Mex; 2017; 82(1):46-84. PubMed ID: 27979414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cancer "fear" in IBD patients: is it still REAL?
    Connelly TM; Koltun WA
    J Gastrointest Surg; 2014 Jan; 18(1):213-8. PubMed ID: 24002760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysplasia in inflammatory bowel diseases.
    Mescoli C; Albertoni L; D'incá R; Rugge M
    Dig Liver Dis; 2013 Mar; 45(3):186-94. PubMed ID: 22974564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
    J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [When is ileocolonoscopy indicated in chronic inflammatory intestinal diseases?].
    Schmidt H
    Wien Med Wochenschr; 2004; 154(3-4):92-4. PubMed ID: 15038583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of "indefinite for dysplasia" in inflammatory bowel disease: correlation with DNA flow cytometry and other risk factors of colorectal cancer.
    Choi WT; Rabinovitch PS; Wang D; Westerhoff M
    Hum Pathol; 2015 Jul; 46(7):939-47. PubMed ID: 25962315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal Cancer Screening in Inflammatory Bowel Disease.
    Sengupta N; Yee E; Feuerstein JD
    Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing Crohn's disease and ulcerative colitis.
    Evans S; Ciclitira PJ
    Practitioner; 1999 Apr; 243(1597):307-14. PubMed ID: 10492973
    [No Abstract]   [Full Text] [Related]  

  • 35. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L; Miheller P; Tulassay Z
    Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathology of dysplasia and cancer in inflammatory bowel disease.
    Mescoli C; Frego M; Rugge M
    Ann Ital Chir; 2011; 82(1):11-8. PubMed ID: 21657150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
    Maykel JA; Hagerman G; Mellgren AF; Li SY; Alavi K; Baxter NN; Madoff RD
    Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer and inflammatory bowel disease: bias, epidemiology, surveillance, and treatment.
    Solomon MJ; Schnitzler M
    World J Surg; 1998 Apr; 22(4):352-8. PubMed ID: 9523516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.